Physician

Endocrinology

Dr. Mark C. Lakshmanan practices Endocrinology. He attended University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37 in research and 52 in primary care medicine Mark C. Lakshmanan is a published MD. He has 2 publications published. The most current publication "Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)."

Publications

---

• Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1).
• Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.

Schools

---

• University of Maryland At Baltimore Professional Schools

Doctors Specialties

---

• Endocrinology

Accepted Insurances

---

Education

---

• National Institutes of Health Clinical Center
• Case Western Reserve University - MetroHealth
• University of Maryland School of Medicine
• University of Maryland

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Priya P. Menon, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeremy R. Grogg, MD This Doctor is OpenDoctor Recommended.
	Dr. Maria D. Rivas, MD This Doctor is OpenDoctor Recommended.
	Dr. William H. Landschulz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog